• SENSEX 73,123.83
    -125.56 (--0.17%)
  • BANKNIFTY 54,287.35
    -638.35 (--1.16%)
  • SBI
    950.75 900.80(%)
  • Tonbo Imaging
    1,209.85 1,209.85(%)
  • Cyient
    1,268.00 1,268.00(%)
  • NSE
    1,640.25 1,640.25(%)
  • Bonfiglioli Tran
    527.40 527.40(%)
  • IndusInd Bank
    831.35 750.45(%)
  • Eternal
    317.50 344.75(%)
  • JSW Energy
    440.25 428.00(%)
  • Voltas
    940.00 940.00(%)
  • Swiggy
    174.90 174.90(%)
  • Persistent Systems
    5,688.80 4,242.65(%)
  • Cupid
    302.45 45.40(%)
  • TCS
    2,624.75 3,336.70(%)
  • Infosys
    1,198.30 1,727.85(%)
  • Havells India
    1,003.65 1,003.65(%)
  • PC Jeweller
    17.08 7.45(%)
  • Bharat Forge
    1,680.45 1,265.00(%)
  • C P C L
    1,529.95 1,677.00(%)
  • Netweb Technol.
    4,238.00 2,942.45(%)
  • Lenskart Solut.
    615.80 355.70(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Suven Life Sciences Ltd Miscellaneous

  • Indian Private
  • BSE Code : 4916.0
  • ISIN : INE495B01038
261.35 -7 (-2.55%)
  • As on 24 Oct 2026 (EOD)

  • Today’s Low

    256.60

  • Today’s High

    271.20

  • Open

    268.20

  • Perv Close

    268.20

  • 52W Low

    124.11

  • 52W High

    403.35

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    7,384.78

  • Div & Yield %

    0.00

  • Book Value(₹)

    56.51

  • Debt-Equity Ratio

    -2.55

  • AGM Date

    23-Oct-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    7,384.78

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    28.26

  • BV (₹)

    56.50

  • Sales( ₹ in Cr.)

    7.11

  • NP (in Cr.)

    -64.40

  • NP Var(%)

    -24.0

  • Div%

    0.0

  • CPS (₹)

    -2.10

  • EPS (₹)

    -2.30

  • Traded Value (₹ in Lakhs)

    7,397.49

  • 52 Week High

    403.35

  • 52 Week Low

    124.11

  • Price BSE

    262.0

  • Price NSE

    261.00

  • Market Capital( in Cr.)

    7,397.49

  • P/C Ratio

    -125.90

  • P/E Ratio

    -115.00

  • Price Vs.BV

    -2.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 7.11 6.66 11.69 13.54 11.84 13.48
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 7.11 6.66 11.69 13.54 11.84 13.48
Other Income 13.91 10.73 28.59 14.45 5.32 7.75
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 21.02 17.39 40.28 27.99 17.16 21.23
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.56 0.30 0.26 0.00 0.00 0.00
Employee Cost 24.15 20.82 16.53 15.77 17.46 15.29
Other Manufacturing Expenses 1.62 1.79 1.54 0.93 2.59 0.14
Selling and Administration Expenses 40.17 34.27 23.06 22.95 27.01 27.61
Miscellaneous Expenses 3.52 1.31 1.15 1.52 1.30 0.89
Employee Benefit Expenses 24.15 20.82 16.53 15.77 17.46 15.29
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 70.02 58.49 42.55 41.18 48.37 43.93
Operating Profit -48.99 -41.11 -2.27 -13.18 -31.22 -22.70
Interest 0.26 0.15 0.24 0.40 0.64 0.91
Gross Profit -49.25 -41.26 -2.51 -13.58 -31.86 -23.61
Depreciation 5.61 5.82 6.50 6.54 4.39 4.35
Profit Before Tax -54.86 -47.08 -9.01 -20.12 -36.25 -27.96
Current Tax 0.00 0.00 -1.00 0.00 0.00 0.38
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 -5.70
Reported Net Profit -54.86 -47.08 -8.01 -20.13 -36.25 -22.63
Extraordinary Items 9.54 4.98 12.01 7.79 3.99 0.06
Adjusted Net Profit -64.40 -52.06 -20.02 -27.92 -40.24 -22.69
Adjustment below Net Profit -0.22 -0.06 -0.06 0.19 -0.15 -0.31
P & L Balance brought forward 86.29 133.43 141.49 161.43 197.83 220.77
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 31.20 86.29 133.43 141.49 161.43 197.83
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -2.08 -2.16 -0.37 -0.92 -2.49 -1.78
Earnings Per Share(Adj)-Unit Curr -2.08 -2.16 -0.37 -0.92 -2.29 -1.64
Book Value 51.11 36.66 38.77 39.14 32.74 28.66
Book Value(Adj)-Unit Curr 51.11 36.66 38.77 39.14 30.17 26.41

Shareholding Pattern

  • Promoter Group

    65.47%

  • Public Share Holding

    34.53%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 183,466,264 64.93 183,466,264 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,533,736 0.54 1,533,736 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 185,000,000 65.47 185,000,000 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 100 0.00 100 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,293,748 0.46 1,293,748 16
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 222,670 0.08 204,670 6
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 5,916,657 2.09 5,916,657 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 7,433,175 2.63 7,415,175 29
2] Non Institution
Bodies Corporate 12,887,356 4.56 12,885,356 405
Clearing Members 0 0.00 0 0
Directors of their Relatives 325,637 0.12 325,637 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 4,142,261 1.47 4,142,261 1,413
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,244,743 0.79 2,244,743 1,331
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 20,196,005 7.15 20,196,005 28
Individuals holding nominal share capital up to Rs. 1 lakh 50,026,620 17.70 49,868,114 64,213
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 304,816 0.11 304,816 3
Sub Total 90,129,511 31.90 89,969,005 67,396
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 282,562,686 100.00 282,384,180 67,431

Company Background

Suven Life Sciences LtdMiscellaneous

  • Suven Life Sciences Ltd
  • BSE Code : 4916.0
  • ISIN : INE495B01038

  • Incorporation Year

    1989

  • Registered Office

    #8-2-334 SDE Serene Chambers
    6 th Floor Road No 5 Avenue 7, Hyderabad,
    Telangana-500034

  • Telephone

    91-40-23541142/3311/3315

  • FAX

    91-40-23541152

  • Chairman

    Venkateswarlu Jasti

  • Managing Director

    Venkateswarlu Jasti

  • Company Secretary

    K Sangeetha Laxmi

  • Auditor

    Karvy & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Suven Life Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Suven Life Scie. 261.80 21.03 7.11 -131.56 -5.52
Apollo Hospitals 7,731.95 9,698.00 9,326.20 70.77 17.52
Kovai Medical 5,737.95 1,613.88 1,585.64 24.49 22.01
Vimta Labs 468.95 416.28 407.29 26.32 23.21
One Global Serv 367.00 498.81 498.18 9.70 87.02
Shree Pacetronix 158.10 21.75 21.64 19.05 22.99
Sharma E I Hosp. 79.15 36.09 35.93 21.93 11.58
Fortis Malar 40.21 6.30 0.00 365.55 14.94
Chennai Meena 36.40 38.16 37.04 -66.18 0.00
CCME Global 30.22 0.04 0.00 -159.05 0.00
Transgene Biotek 2.57 1.04 0.26 -12.24 0.00